Prostate Cancer - Results from #1580

FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer. January 2, 2024

Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomy. January 2, 2024

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. January 2, 2024

The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study. January 1, 2024

The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality. January 1, 2024

Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study. January 1, 2024

Heterogeneity of Radiological Progression Patterns and Association with Outcomes in Patients with Metastatic Prostate Cancer. January 1, 2024

Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years' Report from the EAU Robotic Urology Section Scientific Working Group. January 1, 2024

Adding a Coefficient for Race to the 4Kscore Improves Calibration for Black Men. December 29, 2023

Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials. December 29, 2023

A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer. December 29, 2023

Role of adenosine deaminase in prostate cancer progression. December 29, 2023

Prostate-specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma. December 29, 2023

A comparative study of spinal cord compression management in metastatic prostate cancer: Teaching versus non-teaching hospitals in the United States. December 28, 2023

Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk Stratification. December 28, 2023

GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401. December 28, 2023

Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. December 28, 2023

Comparison of Capture Rates of the National Cancer Database Across Race and Ethnicity. December 28, 2023

Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer. December 28, 2023

Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer. December 27, 2023

Page 80 of 1436